ECSP971998A - CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING - Google Patents
CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATINGInfo
- Publication number
- ECSP971998A ECSP971998A ECSP971998A ECSP971998A EC SP971998 A ECSP971998 A EC SP971998A EC SP971998 A ECSP971998 A EC SP971998A EC SP971998 A ECSP971998 A EC SP971998A
- Authority
- EC
- Ecuador
- Prior art keywords
- sugar coating
- steroids
- controlled release
- hormonal steroid
- active agents
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title abstract 4
- 238000009495 sugar coating Methods 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title 1
- 230000003054 hormonal effect Effects 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
En una tableta farmacéutica que comprende una sustancia interna y un recubrimiento de azúcar, en el cual dicha sustancia contiene agentes no farmacéuticamente activos o uno o más agentes no esteroidales, farmacéuticamente activos que son convencionalmente administrados en conjunto con un esteroide hormonal, el mejoramiento que comprende la incorporación de un esteroide hormonal y un esteroide hormonal desprende el promediode control de la cantidad de celulosa micocristalina en dicho recubrimiento azúcar.In a pharmaceutical tablet comprising an internal substance and a sugar coating, wherein said substance contains non-pharmaceutically active agents or one or more non-steroidal, pharmaceutically active agents that are conventionally administered in conjunction with a hormonal steroid, the improvement comprising the incorporation of a hormonal steroid and a hormonal steroid gives off the average control of the amount of mycrystalline cellulose in said sugar coating.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP971998 ECSP971998A (en) | 1997-01-15 | 1997-01-15 | CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP971998 ECSP971998A (en) | 1997-01-15 | 1997-01-15 | CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP971998A true ECSP971998A (en) | 1998-04-07 |
Family
ID=42042832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP971998 ECSP971998A (en) | 1997-01-15 | 1997-01-15 | CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP971998A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11793812B2 (en) | 2016-09-30 | 2023-10-24 | Sumitomo Pharma Switzerland Gmbh | Methods of treating endometriosis |
| US12551447B2 (en) | 2020-05-29 | 2026-02-17 | Sumitomo Pharma Co., Ltd. | Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists |
-
1997
- 1997-01-15 EC ECSP971998 patent/ECSP971998A/en unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11793812B2 (en) | 2016-09-30 | 2023-10-24 | Sumitomo Pharma Switzerland Gmbh | Methods of treating endometriosis |
| US11957684B2 (en) | 2016-09-30 | 2024-04-16 | Sumitomo Pharma Switzerland Gmbh | Treatment of heavy menstrual bleeding associated with uterine fibroids |
| US12551447B2 (en) | 2020-05-29 | 2026-02-17 | Sumitomo Pharma Co., Ltd. | Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4780019A1 (en) | CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATINGS | |
| ATE269709T1 (en) | SUSTAINED-RELEASE TABLET CONTAINING A BLOOD SUGAR-LOWERING ACTIVE AND AN ANTIHYPERGLYCEMIC ACTIVE | |
| ATE251449T1 (en) | FLAVOR-MASKED ORAL PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED DELIVERY | |
| BR0014929A (en) | Drug delivery device, and process for delivering a pharmaceutically active agent to a target tissue within a body | |
| AU4989997A (en) | Soluble form osmotic dose delivery system | |
| ES2137627T3 (en) | NEW COATING COMPOSITION BASED ON A SUGAR, FOR APPLICATION TO COMPRESSED MEDICINAL TABLETS. | |
| FI930862A0 (en) | EN DOSERINGSFORM FOER TIDSVARIERANDE MOENSTER AV LAEKEMEDELOEVERLAOTELSE | |
| ES2153836T3 (en) | MASK COMPOSITION OF THE FLAVOR OF AMARGOS PHARMACEUTICAL AGENTS. | |
| ATE476957T1 (en) | FONDANT-BASED PHARMACEUTICAL COMPOSITION | |
| BG106030A (en) | Pharmaceutical composition | |
| UY27532A1 (en) | DOSAGE FORM OF DUAL CONTROLLED RELEASE. | |
| MX166703B (en) | PHARMACEUTICAL PREPARATION FOR SUSTAINED RELEASE | |
| NO20003159D0 (en) | Double capsule for the administration of active principles in multiple therapies | |
| DE69710757D1 (en) | PHARMACEUTICAL FORM CONTAINING MILNACIPRANE WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE | |
| TR199901669T2 (en) | Required dosage forms and method for the treatment of erectile dysfunction in men. | |
| BR9811381A (en) | Processes for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect, for treating a mammalian organism for cytomegalovirus retinitis, to provide controlled and prolonged administration of an agent effective in obtaining a desired physiological or local or systemic pharmacological, and, prolonged release drug delivery system | |
| AP2001002237A0 (en) | Hydrogel-driven drug dosage form. | |
| WO2002017930A3 (en) | Glucocorticoid blocking agents for increasing blood-brain barrier permeability | |
| KR980700071A (en) | Transdermal System for the Simultaneous Delivery of a Number of Active Principles | |
| AU2002224926A1 (en) | Novel medicament compositions based on anticholinesterase drugs and on a steroid | |
| ES2139002T3 (en) | CYTOTOXIC DRUG THERAPY. | |
| ES2170501T3 (en) | PHARMACEUTICAL COMPOSITION ANTIVIRICA THAT INCLUDES GLYCYRDIC ACID AND AT LEAST A PROTEIN THAT HAS ANTIVIRICAL ACTIVITY. | |
| ECSP971998A (en) | CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING | |
| EP1090639A3 (en) | Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator | |
| CA2348474A1 (en) | Pharmaceutically active composition and dispensing device |